| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ULUFA
|
1.64 | 885.6M | 1.18 | 0.44 | 2.06 | — | — | 76 | 51 | 4.07 | +111.0% | 66 | 7.12 |
|
LIDFA
|
2.55 | 2.8B | 2.69 | 0.87 | — | — | — | 73 | 30 | 4.95 | +60.0% | 67 | 3.64 |
|
GARFA
|
26.52 | 10.5B | 4.39 | 1.76 | — | — | — | 70 | 34 | 36.95 | +25.2% | 66 | 5.83 |
|
CRDFA
|
25.50 | 22.9B | 100.00 | 38.54 | 120.75 | — | — | 34 | 8 | 6.48 | -56.0% | 74 | 2.15 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.